Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-27

FDA Approved: AXUMIN — Original Application (Blue Earth Diagnostics)

View source ↗

Summary

The FDA approves AXUMIN (fluciclovine F-18) in an original application for PET imaging to detect recurrent prostate cancer, with Blue Earth Diagnostics as the m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Axumin (fluciclovine F-18)

Snippet

ORIG AP for AXUMIN (FLUCICLOVINE F-18)